Eleven-year follow-up data continue to show the invasive disease-free survival benefit for node-positive patients seen in previous analyses.

Nuvaxovid had been available under emergency use authorization but the full approval may allow it to better compete with ...

Pfizer-backed CellCentric has secured $120 million in series C funds as the British biotech prepares to take its multiple myeloma drug into pivotal trials.

Power Grid Corporation of India, DLF, Pfizer, New India Assurance, NLC India, and Gujarat Gas are among 104 companies that ...

Madison Realty Capital, a vertically integrated real estate private equity firm focused on real estate private credit, today announced that it has originated a $720 million loan to a joint-venture ...

Here are our five favorite high-yield dividend stocks with which you can start your portfolio.

Zimlovisertib plus tofacitinib shows greater efficacy than tofacitinib alone in reducing Disease Activity Scores in patients ...

The FDA's full approval of Nuvaxovid triggered a $175 million milestone payment to Novavax from Sanofi, related to their ...

Metro Loft and David Werner’s secured $720 million of construction financing to execute New York City’s largest office-resi ...

The U.S. Food and Drug Administration approved Novavax's COVIDd-19 vaccine with age restrictions after a six-week delay.

Founded in 1993, The Motley Fool is a financial services company dedicated to making the world smarter, happier, and richer.

Novavax originally showed its vaccine was safe and effective in a 30,000-person clinical trial. The FDA had been on track to ...